首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2807篇
  免费   19篇
  国内免费   26篇
  2852篇
  2024年   2篇
  2023年   21篇
  2022年   17篇
  2021年   45篇
  2020年   48篇
  2019年   37篇
  2018年   45篇
  2017年   34篇
  2016年   46篇
  2015年   82篇
  2014年   190篇
  2013年   165篇
  2012年   202篇
  2011年   286篇
  2010年   242篇
  2009年   165篇
  2008年   142篇
  2007年   117篇
  2006年   112篇
  2005年   72篇
  2004年   76篇
  2003年   69篇
  2002年   39篇
  2001年   17篇
  2000年   20篇
  1999年   30篇
  1998年   26篇
  1997年   30篇
  1996年   23篇
  1995年   47篇
  1994年   57篇
  1993年   45篇
  1992年   43篇
  1991年   39篇
  1990年   37篇
  1989年   18篇
  1988年   24篇
  1987年   19篇
  1986年   6篇
  1985年   15篇
  1984年   19篇
  1983年   29篇
  1982年   21篇
  1981年   7篇
  1980年   10篇
  1979年   4篇
  1978年   5篇
  1975年   2篇
  1971年   1篇
  1969年   1篇
排序方式: 共有2852条查询结果,搜索用时 0 毫秒
81.
  1. Download : Download high-res image (93KB)
  2. Download : Download full-size image
Highlights
  • •Quantitative proteomics of mitotic chromosome scaffold isolated from chicken DT40 cells.
  • •BAZ1B identified in the isolated mitotic chromosome scaffold localizes to mitotic chromosome axes.
  • •BAZ1B knockout caused prophase delay because of altered chromosome condensation timing and impaired mitosis progression.
  • •BAZ1B knockout did not affect prometaphase chromosome structure.
  相似文献   
82.
N-Methylpyrrolidone is a solvent molecule which has been shown to compete with acetyl-lysine-containing peptides for binding to bromodomains. From crystallographic studies, it has also been shown to closely mimic the acetamide binding motif in several bromodomains, but has not yet been directly pursued as a fragment in bromodomain inhibition. In this paper, we report the elaboration of N-methylpyrrolidone as a potential lead in fragment-based drug design. Firstly, N-methylpyrrolidone was functionalised to provide points for chemical elaboration. Then, the moiety was incorporated into analogues of the reported bromodomain inhibitor, Olinone. X-ray crystallography revealed that the modified analogues showed comparable binding affinity and structural mimicry to Olinone in the bromodomain binding site.  相似文献   
83.
84.
Utrophin is the autosomal homolog of dystrophin, the product of the Duchenne's muscular dystrophy (DMD) locus. Utrophin is of therapeutic interest since its over-expression can compensate dystrophin's absence. Utrophin is enriched at neuromuscular junctions due to heregulin-mediated utrophin-A promoter activation. We demonstrate that heregulin activated MSK1/2 and phosphorylated histone H3 at serine 10 in cultured C2C12 muscle cells, in an ERK-dependent manner. MSK1/2 inhibition suppressed heregulin-mediated utrophin-A activation. MSK1 over-expression potentiated heregulin-mediated utrophin-A activation and chromatin remodeling at the utrophin-A promoter. These results identify MSK1/2 as key effectors modulating utrophin-A expression as well as identify novel targets for DMD therapy.  相似文献   
85.
86.
PurposeThe purpose of this study is to present the first birth of healthy infant born following ICSI using the new permeable cryoprotectant-free sperm vitrification protocol Easy-Sperm®.Principal resultsA 39 years old woman and his 40 years old partner underwent egg donation treatment at IVF-Spain Alicante (Spain). Half of the mature oocytes obtained from a young and healthy donor were fertilized by ICSI, using slow-frozen spermatozoa and the other half with vitrified spermatozoa. A total of 5 blastocysts were obtained on day 5 (3 resulting from vitrified spermatozoa and 2 from frozen sperm). The best embryo, with AA quality (derived from one of the oocytes fertilized with vitrified sperm) was transferred. The woman conceived and, following a normal pregnancy, delivered a healthy boy.ConclusionsTo the best of our knowledge, this is the first case report of a successful pregnancy and delivery of a healthy infant from ICSI with permeable vitrified spermatozoa in an oocyte donation program with transfer on blastocyst stage.  相似文献   
87.
88.
89.
This study investigated factors important to the development of the liquid nitrogen (LN) vapor sperm cryopreservation technique in farmed greenlip abalone Haliotis laevigata, including (1) cryoprotectant agent (CPA) toxicity; (2) cooling temperature (height above LN surface); (3) thawing temperature; (4) sperm to egg ratio; and (5) sugar supplementation, using sperm motility, fertilization rate or integrity/potential of sperm components and organelles as quality assessment indicators. Results suggested that among the single CPAs evaluated 6% dimethyl sulfoxide (Me2SO) would be the most suitable for sperm cryopreservation in this species. The highest post-thaw sperm motility was achieved with the sperm that had been exposed to LN vapor for 10 min at 5.2 cm above the LN surface, thawed and recovered in 60 and 18 °C seawater bathes, respectively after at least 2 h storage in LN. The highest fertilization rates were achieved at a sperm to egg ratio of 10,000:1 or 15,000:1. Addition of 1% glucose or 2% sucrose produced significantly higher post-thaw sperm motility than 6% Me2SO alone. Among the three cryoprotectant solutions further trialled, 6% Me2SO + 1% glucose produced the highest fertilization rate of 83.6 ± 3.7%. Evaluation of sperm has shown that the addition of glucose could significantly improve the sperm plasma membrane integrity and mitochondrial membrane potential. These results demonstrated a positive role of glucose in the improvement of sperm cryopreservation in farmed greenlip abalone.  相似文献   
90.
海月水母精巢发育及排精过程的观察   总被引:1,自引:0,他引:1  
采用实验生态学及显微观察的方法研究了海月水母(Aurelia sp.)的精巢发育及其排精过程,并对其精子活力进行了测定。结果表明:在水温20~22℃的条件下,海月水母碟状体经过40 d生长,达到伞径(7.50±0.71)cm、体重(28.70±6.60)g时,精巢出现并生长发育;经过60 d生长,达到伞径(11.77±0.51)cm、体重(83.54±10.36)g时,精巢发育成熟并开始排精;生长90 d后,精巢开始出现退化,当生长110 d时,精巢退化完全。在精巢发育过程中,其宽度和长度分别伴随海月水母伞径的增长而增宽和伸长,并出现折叠现象。海月水母的排精路线为:精子先粘附于精子细丝上,从精巢排出,继而经过胃循环沟、胃口腕沟,最后由口腕基沟排出体外。在水温22℃、盐度30、p H 8.0的条件下,海月水母精子活力随时间延长而降低,其快速运动时间和寿命分别为4 h 30 min和10 h。本研究结果显示,在适宜的环境条件下,海月水母精巢发育迅速,排精路线与过程相对简单,其精子活力强、寿命长,这种高效的生殖策略为其暴发奠定了基础,这或许也是海月水母能在地球上存活年代久远的原因之一。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号